Navigation Links
Uptake Medical® Expands Executive Team, Announces European General Manager Lloyd Mencinger
Date:9/6/2011

InterVapor, to help this population of patients is truly exciting. Uptake Medical's pioneering approach to lung volume reduction is certain to help improve the quality of life for many emphysema sufferers."

About Emphysema:

Emphysema and chronic bronchitis are captured under the umbrella of Chronic Obstructive Pulmonary Disease (COPD). The Word Health Organization has stated that the incidence of COPD is on the rise, on pace to becoming the third leading cause of death by 2030. In the United States, where nearly 5 million people are diagnosed with emphysema, it already holds this position, with one person dying every 4 minutes. Debilitating and costly, nearly $50 billion was spent on the direct and indirect costs associated with COPD in the U.S. in 2010.

About Uptake Medical:

With headquarters in Tustin, Calif., Uptake Medical develops innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor, is the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body's natural healing process without leaving any foreign materials in the lung. In clinical studies, InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life. More information can be found at www.uptakemedical.com.

Uptake Medical and InterVapor are registered trademarks and trademarks of Uptake Medical.


'/>"/>
SOURCE Uptake Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
2. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
3. Uptake Medical Announces Scott Huennekens Elected to Board of Directors
4. The Harley Medical Group Sees an Uptake in Surgery Bookings for Christmas
5. Uptake Medical Names J.C. MacRae as Chief Financial Officer
6. Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
7. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
8. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
9. BridgePoint Medical®, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss® and Stingray® CTO Recanalization System
10. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
11. IRIDEX Expands ENT Laser Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... 2011 /PRNewswire-iReach/ --  Janet R. Dees, CEO/President of ... opening of its newest vascular access center in Columbus, ... success for American Vascular Access, LLC., and the addition ... R. Dees, CEO/President.   "Our goal has continued ...
... Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a ... of its CLS® Brevius ™ Hip Stem with ... new technology enables surgeons to better match patients, individual ... adjustments. "Following its introduction in Europe earlier ...
Cached Medicine Technology:American Vascular Access Continues Growth in Georgia 2Zimmer Introduces New CLS® Brevius™ Hip Stem with Kinectiv® Technology in the United States 2Zimmer Introduces New CLS® Brevius™ Hip Stem with Kinectiv® Technology in the United States 3
(Date:4/17/2014)... have called for more research to be carried ... in sub-Saharan Africa. In a paper in ... Stothard, working with colleagues in the department of ... in Cleveland Ohio, University of Cambridge and the ... the joint burden of HIV/AIDS and schistosomiasis of ...
(Date:4/16/2014)... GROVE, Ill. April 16, 2014 According to ... colonoscopy in average-risk patients with one to two small ... percent of cases. This may be an appropriate target ... database study to quantify adherence to guidelines for timing ...
(Date:4/15/2014)... the RECIST Working Group published in the European Journal ... refined categorization of tumor response or various aspects of progression ... They found that modeling target lesion tumor growth did ... that of the other components of progression. The RECIST Working ...
(Date:4/14/2014)... , Alexandria, Va., USA The International and American ... titled "Rare Bone Diseases and Their Dental, Oral, and ... Akintoye, Andrea B. Burke, Alison M. Boyce, Michael Collins, ... Mary Scott Ramnitz, Martha J. Somerman and J. Timothy ...
(Date:4/14/2014)... ,, DALLAS April 14, 2014 Popular web ... lay people to read and doesn,t address the appropriate ... UT Southwestern Medical Center gastroenterologists suggests. , In a ... online patient education materials for colorectal cancer screening were ...
Breaking Medicine News(10 mins):Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Rare bone diseases and their dental, oral and craniofacial manifestations 2Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3
... ... videos out today to support TacheBack - the fundraiser asking men to grow a ,tache in ... Everyman - the UK,s leading male cancer campaign - which launched TacheBack in 2003. , ... (PRWeb UK) 13 August, 2009 -- TV personality ...
... ... of voice technology for the NHS, has today announced that following an extensive tender ... along with 5 other providers for the provision of digital dictation workflow software and ... ...
... ... Angeles has been legalizing medical cannabis. Medical cannabis is, of course, already legalized; ... against medical cannabis have hampered any growth in this industry. , ... (PRWEB) August 13, 2009 -- One ...
... , GRAND RAPIDS, Mich., Aug. 13 The number ... Although younger people have experienced the steepest declines, all age groups ... Cancer Research , a journal of the American Association for Cancer ... including prevention, early detection and better treatment, have resulted in profound ...
... , , , , ... US, Inc. ("Astellas") announced today an update regarding the status of ... Food and Drug Administration,s (FDA) decision regarding its Citizen Petition. The ... Washington, D.C. The company is disappointed in the court,s decision and ...
... , ISELIN, N.J., Aug. 12 Pharmos Corporation (Pink ... ended June 30, 2009. , , Second Quarter Ended ... net loss of $2.3 million, or $0.05 per share, for the second quarter ... in the second quarter 2008. Cash and cash equivalents totaled $2.9 million at ...
Cached Medicine News:Health News:"Being a Proper Man is About Having a 'tache" Says Keith Lemon 2Health News:"Being a Proper Man is About Having a 'tache" Says Keith Lemon 3Health News:"Being a Proper Man is About Having a 'tache" Says Keith Lemon 4Health News:Yorkshire and Humber NHS Procurement Hub Selects BigHand Voice Platform 2Health News:Los Angeles Medical Cannabis Classes Available 2Health News:Cancer Mortality Rates Experience Steady Decline 2Health News:Cancer Mortality Rates Experience Steady Decline 3Health News:Cancer Mortality Rates Experience Steady Decline 4Health News:Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications 2Health News:Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications 3Health News:Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications 4Health News:Pharmos Corporation Reports 2009 Second Quarter Results 2Health News:Pharmos Corporation Reports 2009 Second Quarter Results 3Health News:Pharmos Corporation Reports 2009 Second Quarter Results 4Health News:Pharmos Corporation Reports 2009 Second Quarter Results 5Health News:Pharmos Corporation Reports 2009 Second Quarter Results 6Health News:Pharmos Corporation Reports 2009 Second Quarter Results 7Health News:Pharmos Corporation Reports 2009 Second Quarter Results 8Health News:Pharmos Corporation Reports 2009 Second Quarter Results 9
... System gets the job done and ... with a review rate far lower ... accurate, physicians are more confident and ... 120 Hematology System, for great performance, ...
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
Creatinine Test Kit (enzymatic), Wavelength: 340 nm. Linear range: up to 20 mg/dL....
Intended for the quantitative determination of creatinine in serum, plasma, or urine. Reaction: Endpoint. Wavelength: 340 nm. Linearity: 10 mg/dL (880 mol/L). Two vials, dry powder reagents....
Medicine Products: